|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: INCARA PHARMACEUTICALS CORP, 10-K405, EX-23.1, 2000-12-15 |
Next: CAREADVANTAGE INC, PRE 14C, 2000-12-15 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEET AND THE CONSOLIDATED STATEMENT OF INCOME FILED AS
PART OF THE ANNUAL REPORT ON FORM 10-K AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH ANNUAL REPORT ON FORM 10-K.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> SEP-30-2000
<PERIOD-START> OCT-01-1999
<PERIOD-END> SEP-30-2000
<CASH> 1,877
<SECURITIES> 4,678
<RECEIVABLES> 197
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 7,155
<PP&E> 827
<DEPRECIATION> 634
<TOTAL-ASSETS> 7,348
<CURRENT-LIABILITIES> 2,493
<BONDS> 43
0
0
<COMMON> 7
<OTHER-SE> 4,805
<TOTAL-LIABILITY-AND-EQUITY> 7,348
<SALES> 0
<TOTAL-REVENUES> 100
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 16,922
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (6,665)
<INCOME-TAX> 0
<INCOME-CONTINUING> (6,665)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (6,665)
<EPS-BASIC> (1.06)<F1>
<EPS-DILUTED> (1.06)<F1>
<FN>
<F1>EPS BASIC
</FN>
</TABLE>
|
|